1
/
의
1
ELK Biotechnology
SKU(재고 관리 코드):ELK3961
Human TNNT2(Troponin T Type 2, Cardiac) ELISA Kit
Human TNNT2(Troponin T Type 2, Cardiac) ELISA Kit
Human TNNT2(Troponin T Type 2, Cardiac) ELISA Kit
Overview
| Product name: | Human cTnT/TNNT2(Troponin T Type 2, Cardiac) ELISA Kit |
| Reactivity: | Human |
| Alternative Names: | CMH2; cTnT; TnTc; Cardiomyopathy,Hypertrophic 2; Cardiac muscle troponin T; TNNT2; Troponin T Type 2, Cardiac |
| Assay Type: | Sandwich |
| Sensitivity: | 6.4 pg/mL |
| Standard: | 1000 pg/mL |
| Detection Range: | 15.63-1000 pg/mL |
| Sample Type: | serum, plasma, tissue homogenates, cell lysates, cell culture supernates and other biological fluids |
| Assay Length: | 3.5h |
| Research Area: | Cardiovascular biology; |
| Test principle: | The test principle applied in this kit is Sandwich enzyme immunoassay. The microtiter plate provided in this kit has been pre-coated with an antibody specific to Human cTnT/TNNT2. Standards or samples are added to the appropriate microtiter plate wells then with a biotin-conjugated antibody specific to Human cTnT/TNNT2. Next, Avidin conjugated to Horseradish Peroxidase (HRP) is added to each microplate well and incubated. After TMB substrate solution is added, only those wells that contain Human cTnT/TNNT2, biotin-conjugated antibody and enzyme-conjugated Avidin will exhibit a change in color. The enzyme-substrate reaction is terminated by the addition of sulphuric acid solution and the color change is measured spectrophotometrically at a wavelength of 450nm ± 10nm. The concentration of Human cTnT/TNNT2 in the samples is then determined by comparing the OD of the samples to the standard curve. |
Standard curve
| Concentration (ng/mL) | OD | Corrected OD |
|---|---|---|
| 1000.00 | 1.925 | 1.838 |
| 500.00 | 1.379 | 1.292 |
| 250.00 | 1.116 | 1.029 |
| 125.00 | 0.782 | 0.695 |
| 62.50 | 0.554 | 0.467 |
| 31.25 | 0.332 | 0.245 |
| 15.63 | 0.226 | 0.139 |
| 0.00 | 0.087 | 0.000 |

Precision
Intra-assay Precision (Precision within an assay):CV%<8%
Three samples of known concentration were tested twenty times on one plate to assess intra-assay precision.
Inter-assay Precision (Precision between assays):CV%<10%
Three samples of known concentration were tested in forty separate assays to assess inter-assay precision.
Recovery
Matrices listed below were spiked with certain level of recombinant cTnT/TNNT2 and the recovery rates were calculated by comparing the measured value to the expected amount of cTnT/TNNT2 in samples.
| Matrix | Recovery range | Average |
|---|---|---|
| serum(n=5) | 85-97% | 91% |
| EDTA plasma(n=5) | 83-99% | 95% |
| Heparin plasma(n=5) | 85-97% | 91% |
Linearity
The linearity of the kit was assayed by testing samples spiked with appropriate concentration of cTnT/TNNT2 and their serial dilutions. The results were demonstrated by the percentage of calculated concentration to the expected.
| Matrix | 1:2 | 1:4 | 1:8 | 1:16 |
|---|---|---|---|---|
| serum(n=5) | 88-102% | 87-102% | 85-96% | 87-101% |
| EDTA plasma(n=5) | 96-103% | 83-96% | 87-98% | 85-97% |
| Heparin plasma(n=5) | 87-96% | 92-105% | 89-102% | 92-101% |
Share
